Search
+

Bajaj Healthcare Share Price

  • 328.900.45 (0.14%)
  • Volume: 13,594
  • Live
  • Last Updated On: 26 Apr, 2024, 11:22 AM IST
Loading...

Bajaj Healthcare share price insights

View All
  • Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

  • Company has spent 3.4% of its operating revenues towards interest expenses and 7.1% towards employee cost in the year ending 31 Mar, 2023. (Source: Standalone Financials)

  • Stock gave a 3 year return of 34.81% as compared to Nifty Smallcap 100 which gave a return of 99.99%. (as of last trading session)

  • Stock generated 34.81% return as compared to Nifty Pharma which gave investors 39.84% return over 3 year time period. (as of last trading session)

  • Bajaj Healthcare Ltd. share price moved down by -0.23% from its previous close of Rs 328.45. Bajaj Healthcare Ltd. stock last traded price is 327.70

    Share PriceValue
    Today/Current/Last327.70
    Previous Day328.45328.50

InsightsBajaj Healthcare

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    -18.34
    EPS - TTM
    (₹)
    -18.22
    MCap
    (₹ Cr.)
    919.58
    Sectoral MCap Rank
    71
    PB Ratio
    (x)
    2.51
    Div Yield
    (%)
    0.30
    Face Value
    (₹)
    5.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    -
    VWAP
    (₹)
    329.01
    52W H/L
    (₹)
    513.40 / 275.70

    Bajaj Healthcare Share Price Returns

    1 Day0.14%
    1 Week4.58%
    1 Month10.44%
    3 Months-1.78%
    1 Year4.16%
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Bajaj Healthcare belongs to analysts' top-rated companies list?

    View Stock Screeners

    Bajaj Healthcare Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Bajaj Healthcare Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Peer Comparison

    • Bajaj Healthcare Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 34.81% as compared to Nifty Smallcap 100 which gave a return of 99.99%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 34.81% return as compared to Nifty Pharma which gave investors 39.84% return over 3 year time period. (as of last trading session)
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 34.81% as compared to Nifty Smallcap 100 which gave a return of 99.99%. (as of last trading session)
      • Stock Returns vs Nifty Pharma

        Stock generated 34.81% return as compared to Nifty Pharma which gave investors 39.84% return over 3 year time period. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Bajaj Healthcare-18.342.5111.7017.424.7717.5812.046.3915.591.171.13-18.56
      Kopran Ltd31.372.886.198.914.1915.287.644.945.652.250.172.21
      Bliss GVS Pharma13.781.328.0112.086.121.8215.4910.206.833.610.112.86
      Lincoln Pharma13.622.3714.5019.8912.4110.1520.0814.2836.405.080.000.05
      Panacea Biotec-71.331.03-4.04-9.09-2.61-3.71-18.57-7.33-5.431.710.02-0.04
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Jagsonpal Pharm
      • Nectar Lifesc
      • Ind-Swift Labs
      • Albert David
      • Zim Laboratories

      Choose from Stocks

      Peers InsightsBajaj Healthcare

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 34.81% as compared to Nifty Smallcap 100 which gave a return of 99.99%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 34.81% return as compared to Nifty Pharma which gave investors 39.84% return over 3 year time period. (as of last trading session)

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Bajaj Healthcare Shareholding Pattern

      • QOQ Change

      • Total Shareholdings

      • Loading...
        Showing Bajaj Healthcare Shareholding as on 31 Mar 2024
        Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
        Promoters67.7367.7367.6967.49
        Pledge0.000.000.000.00
        FII0.530.740.660.69
        DII0.430.480.430.34
        Mutual Funds0.000.000.000.00
        Others31.3031.0431.2231.48
      • Showing Shareholding as on 31 Mar 2024
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters1,86,93,04267.73 %0.00
        Pledge00.00 %0.00
        FII1,46,1070.53 %-0.20
        DII1,20,1180.43 %-0.04
        MF1180.00 %0.00
        Others86,39,13331.30 %0.25

      MF Ownership

      MF Ownership as on 31 March 2024

      Corporate Actions

      • Bajaj Healthcare Board Meeting/AGM

      • Bajaj Healthcare Dividends

      • Others
      • Meeting DateAnnounced onPurposeDetails
        Feb 09, 2024Feb 05, 2024Board MeetingQuarterly Results
        Nov 09, 2023Nov 03, 2023Board MeetingQuarterly Results
        Sep 30, 2023Sep 08, 2023AGMRs.1.0000 per share(20%)Final Dividend & A.G.M.
        Aug 14, 2023Aug 07, 2023Board MeetingQuarterly Results
        Aug 05, 2023Jul 06, 2023POM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final20%1.0Sep 22, 2023May 30, 2023
        Final30%1.5Sep 22, 2022May 17, 2022
        Special5%0.5Sep 28, 2021Jun 10, 2021
        Final5%0.5Sep 28, 2021Jun 09, 2021
        Special5%0.5Dec 01, 2020Nov 20, 2020
      • All TypesEx-DateRecord DateAnnounced onDetails
        SplitsSep 28, 2021Sep 29, 2021Aug 13, 2021Split: Old FV10.0| New FV:5.0
        BonusApr 09, 2019Apr 10, 2019Feb 19, 2019Bonus Ratio: 1 share(s) for every 1 shares held

      About Bajaj Healthcare

      Bajaj Healthcare Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 921.92 Crore) operating in Pharmaceuticals sector. Bajaj Healthcare Ltd. key Products/Revenue Segments include Pharmaceuticals and Sale of services for the year ending 31-Mar-2023. Show More

      • Executives

      • Auditors

      • SR

        Sajankumar R Bajaj

        Chairman & Managing Director
        AC

        Anil C Jain

        Managing Director
        RH

        Rupesh H Nikam

        WholeTime Director & CFO
        DS

        Dhananjay S Halte

        Whole Time Director
        Show More
      • Chaturvedi & Agrawal
        Paresh Rakesh & Associates

      Key Indices Listed on

      S&P BSE SmallCap, S&P BSE Healthcare, S&P BSE AllCap, + 1 more

      Address

      602-606, Bhoomi Velocity Infotech Park,Plot No. B-39, B-39/A, B-39 A/1,Road No. 23,Thane, Maharashtra - 400604

      FAQs about Bajaj Healthcare share

      • 1. What's Bajaj Healthcare share price today and what are Bajaj Healthcare share returns ?
        Bajaj Healthcare share price was Rs 327.70 as on 26 Apr, 2024, 10:05 AM IST. Bajaj Healthcare share price was down by 0.23% based on previous share price of Rs 334.05. Bajaj Healthcare share price trend:
        • Last 1 Month: Bajaj Healthcare share price moved up by 10.04%
        • Last 3 Months: Bajaj Healthcare share price moved down by 2.14%
        • Last 12 Months: Bajaj Healthcare share price moved up 3.78%
        • Last 3 Years: Bajaj Healthcare Share price moved remain unchanged by N.A.
      • 2. What is the market cap of Bajaj Healthcare?
        Bajaj Healthcare share has a market capitalization of Rs 919.58 Cr. Within Pharmaceuticals sector, it's market cap rank is 71.
      • 3. What is Bajaj Healthcare's 52 week high / low?
        In last 52 weeks Bajaj Healthcare share had a high price of Rs 513.40 and low price of Rs 275.70
      • 4. Who are the peers for Bajaj Healthcare in Pharmaceuticals sector?
        Within Pharmaceuticals sector Bajaj Healthcare, Panacea Biotec Ltd., Jagsonpal Pharmaceuticals Ltd., Nectar Lifesciences Ltd., Ind-Swift Laboratories Ltd., Albert David Ltd., Lincoln Pharmaceuticals Ltd., Bliss GVS Pharma Ltd., Zim Laboratories Ltd., Kopran Ltd. and Kilitch Drugs(I) Ltd. are usually compared together by investors for analysis.
      • 5. Who's the owner of Bajaj Healthcare?
          • Promoter holding has gone up from 67.49 (30 Jun 2023) to 67.73 (31 Mar 2024)
          • Domestic Institutional Investors holding has gone up from 0.34 (30 Jun 2023) to 0.43 (31 Mar 2024)
          • Foreign Institutional Investors holding have gone down from 0.69 (30 Jun 2023) to 0.53 (31 Mar 2024)
          • Other investor holding have gone down from 31.48 (30 Jun 2023) to 31.3 (31 Mar 2024)
      • 6. How can I quickly analyze Bajaj Healthcare stock?
        Key Metrics for Bajaj Healthcare are:
        • PE Ratio of Bajaj Healthcare is -18.34
        • Price/Sales ratio of Bajaj Healthcare is 1.25
        • Price to Book ratio of Bajaj Healthcare is 2.51
      • 7. Is the Bajaj Healthcare profitable ?
        On Standalone basis, Bajaj Healthcare reported a total income and profit of Rs 109.37 Cr and Rs -2.20 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2023-03-31 was Rs 674.89 Cr and Rs 43.02 Cr.

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times